Back to VC Directory

Sofinnova Investments

Venture Capital · Menlo Park (United States), Boston (United States), New York (United States) · Founded 1972

About

Sofinnova is a clinical-stage biopharmaceutical venture capital firm with a focus on therapeutic drugs. They invest in both private and public equity companies across the U.S. and Europe, partnering with entrepreneurs to advance cures and improve lives. Their deep scientific knowledge is a core component of their investment strategy.

Investment Stages

Series A, Series B

Industry Focus

BioTech, Healthcare, Neurology, Orphan Diseases, Pain Management, Pharma

Portfolio Companies

Axonis Therapeutics, Seaport Therapeutics, Capstan Therapeutics, Avenzo Therapeutics, BioAge Labs, OnCusp Therapeutics, Aiolos Bio, Star Therapeutics, Rapport Therapeutics, Alkeus Pharmaceuticals, ArriVent, Rayzebio, Gyroscope Therapeutics, Atsenatx, Vera Therapeutics, Visen Pharma, Aerovate Therapeutics, Bolt Biotherapeutics, Athira Pharma, Intrepid Bioscience, North Sea Therapeutics, Promedior, Aeovian, Karuna Therapeutics, CinCor Pharma, Inozyme Pharma, Quanta, XyloCor Therapeutics, Kiniksa, Neurana Pharmaceuticals, VelosBio, Akouos, Y-mAbs, Pionyr Immunotherapeutics, Medeor Therapeutics, Incarda Therapeutics, Dermavant Sciences, Seres Therapeutics, NextCure, Merus, Iterum Therapeutics, Entasis Therapeutics, Edge Therapeutics, Afyx Therapeutics, Dauntless Pharmaceuticals, Chiasma, Checkmate Pharmaceuticals, Rainier Therapeutics, Audentes Therapeutics, Atryx, Ascendis Pharma, Apellis Pharmaceuticals, Antiva Biosciences, Amplyx Pharmaceuticals, ZS Pharma, Versartis, Tesaro, Spark Therapeutics, Sophiris Bio, Sarcode Bioscience, Prothena, Principia Biopharma, Ophthotech, Obseva, NuCana, Natera, Synlogic, Biohaven, Innocoll, Histogenics, First Aid Shot Therapy, Civitas Therapeutics, Auris Medical, Alimera Sciences, Aclaris Therapeutics, Vicept Therapeutics, Trius Therapeutics, PregLem, Intellikine, Hyperion Therapeutics, Galerix, Coherus, C2N Diagnostics, Amarin, Aerie Pharmaceuticals, Orexigen, Mallinckrodt Pharmaceuticals, NextWave Pharmaceuticals, Marinus Pharmaceuticals, MedImmune, Catalyst Biosciences, Anthera Pharmaceuticals, Alvine Pharmaceuticals, Molecular Templates, Tensys Medical, Saegis Pharmaceuticals, Biovail, Humanigen, Actelion, Anesiva, Seattle Genetics, PharmaSonics, Intermune, Entelos, Actelion

Team (9)

  • David Kabakoff - Executive Partner, Private Equity
  • James Healy - Managing Partner
  • Maha Katabi - General Partner
  • Maha Radhakrishnan - Executive Partner, Private Equity
  • Chris Carpenter - Executive Partner, Private Equity
  • Eric Delbridge - General Partner, Public Equity
  • Jakob Dupont - Executive Partner, Private Equity
  • Jonathan Leff - Executive Partner, Private Equity
  • Lars Ekman - Executive Partner, Private Equity